Neoadjuvant therapy: clinical trials recruiting now
3
Recruiting trials
12
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Adverse Reaction | 1 |
| Anlotinib | 1 |
| Breast Cancer | 1 |
| Chemotherapy | 1 |
| Efficacy | 1 |
| Lung Cancer (NSCLC) | 1 |
| NSCLC | 1 |
| Nab-paclitaxel | 1 |
| Neoadjuvant Therapy | 1 |
| Tislelizumab | 1 |
| Vitamin D | 1 |
Recruiting trials involving Neoadjuvant therapy
- A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
- Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer
- Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study
Common questions
How many recruiting trials involve Neoadjuvant therapy?
3 recruiting trials across 12 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.